Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04783441 · ClinicalTrials.gov registry record · NA
Use of CGM in Kidney Transplant Recipients
A NA study of Diabetes Mellitus, Type 2 and Kidney Transplant; Complications, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04783441 is a NA study of Diabetes Mellitus, Type 2 and Kidney Transplant; Complications that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 80 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04783441, a NA study of Diabetes Mellitus, Type 2 and Kidney Transplant; Complications, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
Conditions Studied
Interventions
- DEVICE Dexcom G6
- DEVICE Dexcom G6 blinded sensor
Study Locations (1)
California
- UC Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04783441
The ClinicalTrials.gov registry entry for NCT04783441 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Dexcom G6 is the first listed.
NCT04783441 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04783441 about?
NCT04783441 is a clinical study titled "Use of CGM in Kidney Transplant Recipients". The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
What is the current status of trial NCT04783441?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-06-29. Estimated completion is 2026-12-31.
What conditions does trial NCT04783441 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Kidney Transplant; Complications, Insulin Dependent Diabetes.
What interventions are being tested in trial NCT04783441?
The interventions under investigation include: Dexcom G6 (DEVICE), Dexcom G6 blinded sensor (DEVICE).
Who is sponsoring clinical trial NCT04783441?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04783441 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Diabetes Mellitus, Type 2
All registered trials for this condition
Kidney Transplant; Complications
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.